Five-year recurrence rate of lentigo maligna after treatment with imiquimod.

Kai, A C

Five-year recurrence rate of lentigo maligna after treatment with imiquimod. [electronic resource] - The British journal of dermatology Jan 2016 - 165-8 p. digital

Publication Type: Clinical Study; Journal Article

1365-2133

10.1111/bjd.14311 doi


Aged
Aged, 80 and over
Aminoquinolines--therapeutic use
Antineoplastic Agents--therapeutic use
Facial Neoplasms--drug therapy
Female
Follow-Up Studies
Humans
Hutchinson's Melanotic Freckle--drug therapy
Imiquimod
Male
Middle Aged
Neoplasm Recurrence, Local--etiology
Skin Neoplasms--drug therapy